Table Of Contents:

	7
1.1 Industry Definition and Research Scope	7
1.1.1 Industry Definition	7
1.1.2 Research Scope	8
1.2 Research Methodology	11
1.2.1 Overview of Market Research Methodology	11
1.2.2 Market Assumption	12
1.2.3 Secondary Data	12
1.2.4 Primary Data	12
1.2.5 Data Filtration and Model Design	13
1.2.6 Market Size/Share Estimation	14
1.2.7 Research Limitations	15
1.3 Executive Summary	16
2 Market Overview and Dynamics	19
2.1 Market Size and Forecast	19
2.1.1 Impact of COVID-19 on World Economy	20
2.1.2 Impact of COVID-19 on the Market	22
2.2 Major Growth Drivers	24
2.3 Market Restraints and Challenges	31
2.4 Emerging Opportunities and Market Trends	34
2.5 Porter’s Fiver Forces Analysis	38
3 Segmentation of North America Market by Offering	42
3.1 Market Overview by Offering	42
3.2 Instruments	44
3.3 Consumables	45
3.4 Sequencing Services	46
4 Segmentation of North America Market by Sequencing Type	47
4.1 Market Overview by Sequencing Type	47
4.2 Sanger Sequencing	49
4.3 Next Generation Sequencing	50
4.4 Other Sequencing Types	51
5 Segmentation of North America Market by Technology	52
5.1 Market Overview by Technology	52
5.2 Sequencing by Synthesis	54
5.3 Ion Semiconductor Sequencing	55
5.4 Chain Termination Sequencing	56
5.5 Pyrosequencing	57
5.6 Sequencing by Ligation (SBL)	58
5.7 Single-Molecule Real-Time Sequencing (SMRT)	59
5.8 Nanopore Sequencing	60
5.9 Other Technologies	61
6 Segmentation of North America Market by Application	62
6.1 Market Overview by Application	62
6.2 Biomarker Discovery	64
6.3 Diagnostics	65
6.4 Personalized Medicine	66
6.5 Reproductive Health	67
6.6 Forensics	68
6.7 Other Applications	69
7 Segmentation of North America Market by End User	70
7.1 Market Overview by End User	70
7.2 Academics and Research Organizations	72
7.3 Pharmaceutical and Biotechnology Companies	73
7.4 Hospitals & Clinics	74
7.5 Other End Users	75
8 North America Market 2021-2031 by Country	76
8.1 Overview of North America Market	76
8.2 U.S.	79
8.3 Canada	82
8.4 Mexico	84
9 Competitive Landscape	86
9.1 Overview of Key Vendors	86
9.2 New Product Launch, Partnership, Investment, and M&A	89
9.3 Company Profiles	90
Agilent Technologies Inc.	90
BGI Genomics Co., Ltd.	92
Bio-Rad Laboratories Inc.	93
Danaher Corporation (Integrated DNA Technologies Inc.)	94
Eurofins Scientific SE	95
F. Hoffmann-La Roche Ltd.	96
Illumina Inc.	97
Merck KGaA	98
Pacific Biosciences of California Inc.	99
PerkinElmer Inc.	100
Thermo Fisher Scientific Inc.	101
RELATED REPORTS	102

List Of Tables:


Table 1.  Snapshot of North America DNA Sequencing Market in Balanced Perspective, 2021-2031	17
Table 2. World Economic Outlook, 2021-2031	21
Table 3. World Health Spending by Region, $ bn, 2013-2020	30
Table 4.  Main Product Trends and Market Opportunities in North America DNA Sequencing Market	34
Table 5. North America DNA Sequencing Market by Offering, 2021-2031, $ mn	42
Table 6. North America DNA Sequencing Market by Sequencing Type, 2021-2031, $ mn	47
Table 7. North America DNA Sequencing Market by Technology, 2021-2031, $ mn	52
Table 8. North America DNA Sequencing Market by Application, 2021-2031, $ mn	62
Table 9. North America DNA Sequencing Market by End User, 2021-2031, $ mn	70
Table 10. North America DNA Sequencing Market by Country, 2021-2031, $ mn	77
Table 11. U.S. DNA Sequencing Market by Offering, 2021-2031, $ mn	81
Table 12. U.S. DNA Sequencing Market by Sequencing Type, 2021-2031, $ mn	81
Table 13. U.S. DNA Sequencing Market by End User, 2021-2031, $ mn	81
Table 14. Canada DNA Sequencing Market by Offering, 2021-2031, $ mn	83
Table 15. Canada DNA Sequencing Market by Sequencing Type, 2021-2031, $ mn	83
Table 16. Canada DNA Sequencing Market by End User, 2021-2031, $ mn	83
Table 17. Mexico DNA Sequencing Market by Offering, 2021-2031, $ mn	85
Table 18. Mexico DNA Sequencing Market by Sequencing Type, 2021-2031, $ mn	85
Table 19. Mexico DNA Sequencing Market by End User, 2021-2031, $ mn	85
Table 20. Agilent Technologies Inc.: Company Snapshot	90
Table 21. Agilent Technologies Inc.: Business Segmentation	91
Table 22. Agilent Technologies Inc.: Product Portfolio	91

List Of Figures:


Figure 1. Research Method Flow Chart	11
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation	14
Figure 3. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031	16
Figure 4. North America DNA Sequencing Market, 2021-2031, $ mn	19
Figure 5. Impact of COVID-19 on Business	22
Figure 6. Primary Drivers and Impact Factors of North America DNA Sequencing Market	24
Figure 7. World Number of Deaths by Cause in 2017	27
Figure 8. World Number of Deaths from Cancers in 2017	28
Figure 9.  Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million	29
Figure 10. World Population 65 and Over, % of Total Population, 1950-2060	29
Figure 11. Primary Restraints and Impact Factors of North America DNA Sequencing Market	31
Figure 12. Investment Opportunity Analysis	35
Figure 13. Porter’s Fiver Forces Analysis of North America DNA Sequencing Market	38
Figure 14. Breakdown of North America DNA Sequencing Market by Offering, 2021-2031, % of Revenue	43
Figure 15. North America Addressable Market Cap in 2022-2031 by Offering, Value ($ mn) and Share (%)	43
Figure 16. North America DNA Sequencing Market by Offering: Instruments, 2021-2031, $ mn	44
Figure 17. North America DNA Sequencing Market by Offering: Consumables, 2021-2031, $ mn	45
Figure 18. North America DNA Sequencing Market by Offering: Sequencing Services, 2021-2031, $ mn	46
Figure 19. Breakdown of North America DNA Sequencing Market by Sequencing Type, 2021-2031, % of Sales Revenue	48
Figure 20. North America Addressable Market Cap in 2022-2031 by Sequencing Type, Value ($ mn) and Share (%)	48
Figure 21. North America DNA Sequencing Market by Sequencing Type: Sanger Sequencing, 2021-2031, $ mn	49
Figure 22. North America DNA Sequencing Market by Sequencing Type: Next Generation Sequencing, 2021-2031, $ mn	50
Figure 23. North America DNA Sequencing Market by Sequencing Type: Other Sequencing Types, 2021-2031, $ mn	51
Figure 24. Breakdown of North America DNA Sequencing Market by Technology, 2021-2031, % of Sales Revenue	53
Figure 25. North America Addressable Market Cap in 2022-2031 by Technology, Value ($ mn) and Share (%)	53
Figure 26. North America DNA Sequencing Market by Technology: Sequencing by Synthesis, 2021-2031, $ mn	54
Figure 27. North America DNA Sequencing Market by Technology: Ion Semiconductor Sequencing, 2021-2031, $ mn	55
Figure 28. North America DNA Sequencing Market by Technology: Chain Termination Sequencing, 2021-2031, $ mn	56
Figure 29. North America DNA Sequencing Market by Technology: Pyrosequencing, 2021-2031, $ mn	57
Figure 30. North America DNA Sequencing Market by Technology: Sequencing by Ligation (SBL), 2021-2031, $ mn	58
Figure 31. North America DNA Sequencing Market by Technology: Single-Molecule Real-Time Sequencing (SMRT), 2021-2031, $ mn	59
Figure 32. North America DNA Sequencing Market by Technology: Nanopore Sequencing, 2021-2031, $ mn	60
Figure 33. North America DNA Sequencing Market by Technology: Other Technologies, 2021-2031, $ mn	61
Figure 34. Breakdown of North America DNA Sequencing Market by Application, 2021-2031, % of Revenue	63
Figure 35. North America Addressable Market Cap in 2022-2031 by Application, Value ($ mn) and Share (%)	63
Figure 36. North America DNA Sequencing Market by Application: Biomarker Discovery, 2021-2031, $ mn	64
Figure 37. North America DNA Sequencing Market by Application: Diagnostics, 2021-2031, $ mn	65
Figure 38. North America DNA Sequencing Market by Application: Personalized Medicine, 2021-2031, $ mn	66
Figure 39. North America DNA Sequencing Market by Application: Reproductive Health, 2021-2031, $ mn	67
Figure 40. North America DNA Sequencing Market by Application: Forensics, 2021-2031, $ mn	68
Figure 41. North America DNA Sequencing Market by Application: Other Applications, 2021-2031, $ mn	69
Figure 42. Breakdown of North America DNA Sequencing Market by End User, 2021-2031, % of Revenue	71
Figure 43. North America Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%)	71
Figure 44. North America DNA Sequencing Market by End User: Academics and Research Organizations, 2021-2031, $ mn	72
Figure 45. North America DNA Sequencing Market by End User: Pharmaceutical and Biotechnology Companies, 2021-2031, $ mn	73
Figure 46. North America DNA Sequencing Market by End User: Hospitals & Clinics, 2021-2031, $ mn	74
Figure 47. North America DNA Sequencing Market by End User: Other End Users, 2021-2031, $ mn	75
Figure 48. Breakdown of North America DNA Sequencing Market by Country, 2021 and 2031, % of Revenue	77
Figure 49. Contribution to North America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)	78
Figure 50. U.S. DNA Sequencing Market, 2021-2031, $ mn	80
Figure 51. Canada DNA Sequencing Market, 2021-2031, $ mn	82
Figure 52.  DNA Sequencing Market in Mexico, 2021-2031, $ mn	84
Figure 53. Growth Stage of North America DNA Sequencing Industry over the Forecast Period	86

Selected Key Players: 
Agilent Technologies Inc.
BGI Genomics Co., Ltd.
Bio-Rad Laboratories Inc.
Danaher Corporation (Integrated DNA Technologies Inc.)
Eurofins Scientific SE
F. Hoffmann-La Roche Ltd.
Illumina Inc.
Merck KGaA
Pacific Biosciences of California Inc.
PerkinElmer Inc.
Thermo Fisher Scientific Inc. 
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)